InterMune Sale Looms as Lung Drug Nears FDA Nod: Real M&A – Bloomberg

InterMune Sale Looms as Lung Drug Nears FDA Nod: Real M&A
Bloomberg
Novartis, Europe's largest drugmaker, makes Seebri for smoker's cough, which competes with Glaxo's Advair, the world's best-selling drug for that condition and asthma. Gilead, which focuses on HIV and hepatitis C medicines, expanded into treatments for

and more »

View full post on world asthma day – Google News

Leave a Reply

Your email address will not be published. Required fields are marked *